Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by deeppocket83on Nov 07, 2016 2:24pm
264 Views
Post# 25433414

Takeda

TakedaQuiet day today so i thought why not write something...

Thinking about the Salix rumour made think a little more and the conclusion i have is that I don't think Valeant really pushed the offer off the table for all of Valeant. I still think Takeda is working with TPG Equity Firm and not alone. If they thought Valeant was attractive enough then I think now is a better time for them to purchase, consider they renegotiated the debt terms. Relistor is out and doing well plus lots in the pipline coming up for Valeant that will generate lots of profit.

Also looks like Takeda will also be 2Billion dollars richer: https://www.reuters.com/article/us-takeda-pharma-sale-idUSKBN12X2D9

<< Previous
Bullboard Posts
Next >>